Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renovorx Inc (NQ: RNXT )

2.030 -0.050 (-2.40%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 147
Open 2.030
Bid (Size) 2.030 (1)
Ask (Size) 2.210 (1)
Prev. Close 2.080
Today's Range 2.030 - 2.030
52wk Range 1.500 - 5.745
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RenovoRx Initiates Patient Enrollment at University of Texas Southwestern Medical Center for Pivotal Phase III TIGeR-PaC Clinical Trial
From RenovoRx, Inc.
Via Business Wire
RenovoRx Announces Late-Breaking Oral Presentation at 2023 ESMO World Congress on Gastrointestinal Cancer
From RenovoRx, Inc.
Via Business Wire

Performance

YTD
-23.40%
-23.40%
1 Month
-25.09%
-25.09%
3 Month
-61.33%
-61.33%
6 Month
+12.78%
+12.78%
1 Year
+9.77%
+9.77%

More News

Read More
RenovoRx to Present at the LD Micro Invitational XIII Conference
From RenovoRx, Inc.
Via Business Wire
RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
From RenovoRx, Inc.
Via Business Wire
RenovoRx Sponsors Pancreatic Cancer Action Network’s PurpleStride® Event
From RenovoRx, Inc.
Via Business Wire
RenovoRx to Participate in the Aegis Capital Virtual Conference on May 3, 2023
From RenovoRx, Inc.
Via Business Wire
RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors
From RenovoRx, Inc.
Via Business Wire
RenovoRx Presenting Phase III Clinical Trial Interim Analysis Data of the TIGeR-PaC Study at American Association for Cancer Research Annual Meeting Underway in Orlando, Florida
From RenovoRx, Inc.
Via Business Wire
RenovoRx Appoints Leesa Gentry as Senior Vice President of Clinical Operations
From RenovoRx, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From RenovoRx, Inc.
Via Business Wire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
US Stocks Open Higher; Dow Jumps 150 Points
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
RenovoRx Announces Positive New Data from Phase III Clinical Trial Interim Analysis: 60% Survival Benefit and Fewer Side Effects than Systemic Chemotherapy
From RenovoRx, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
RenovoRx’s Principal Investigator of Phase III Clinical Trial Discusses Positive Interim Results on Patients with Locally Advanced Pancreatic Cancer on OncologyTube
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
RenovoRx's Targeted Prostate Cancer Treatment Shows Positive Trend In Median Overall Survival Versus Standard Care
Via Benzinga
RenovoRx Phase III Open Label TIGeR-PaC Interim Analysis Shows Promising Data That Support Continued Clinical Investigation of RenovoGemTM as a Treatment Option for Locally Advanced Pancreatic Cancer
From RenovoRx, Inc.
Via Business Wire
RenovoRx, Inc. Full-year 2022 Results Provide Clues Supporting A Near-Term Catalyst-Fueled Breakout ($RNXT)
Via AB Newswire
RenovoRx Reports Full Year 2022 Financial Results and Achievement of Important Phase III Clinical Study Milestone
From RenovoRx, Inc.
Via Business Wire
RenovoRx, Inc. Shares Surge 117% YTD As Multiple Catalysts Come Into Focus ($RNXT)
Via AB Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.